Unknown

Dataset Information

0

Sox17 regulates liver lipid metabolism and adaptation to fasting.


ABSTRACT: Liver is a major regulator of lipid metabolism and adaptation to fasting, a process involving PPARalpha activation. We recently showed that the Vnn1 gene is a PPARalpha target gene in liver and that release of the Vanin-1 pantetheinase in serum is a biomarker of PPARalpha activation. Here we set up a screen to identify new regulators of adaptation to fasting using the serum Vanin-1 as a marker of PPARalpha activation. Mutagenized mice were screened for low serum Vanin-1 expression. Functional interactions with PPARalpha were investigated by combining transcriptomic, biochemical and metabolic approaches. We characterized a new mutant mouse in which hepatic and serum expression of Vanin-1 is depressed. This mouse carries a mutation in the HMG domain of the Sox17 transcription factor. Mutant mice display a metabolic phenotype featuring lipid abnormalities and inefficient adaptation to fasting. Upon fasting, a fraction of the PPAR?-driven transcriptional program is no longer induced and associated with impaired fatty acid oxidation. The transcriptional phenotype is partially observed in heterozygous Sox17+/- mice. In mutant mice, the fasting phenotype but not all transcriptomic signature is rescued by the administration of the PPARalpha agonist fenofibrate. These results identify a novel role for Sox17 in adult liver as a modulator of the metabolic adaptation to fasting.

SUBMITTER: Rommelaere S 

PROVIDER: S-EPMC4139292 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4648819 | biostudies-literature
| S-EPMC3958042 | biostudies-literature
| S-EPMC3007132 | biostudies-literature
| S-EPMC9730692 | biostudies-literature
| S-EPMC2676208 | biostudies-literature
| S-EPMC8492312 | biostudies-literature
| S-EPMC3817107 | biostudies-literature
| S-EPMC5640785 | biostudies-literature
| S-EPMC10308158 | biostudies-literature
| S-EPMC4350020 | biostudies-literature